BioChronicles Blog

Quantum Dots

Unlock new potential in quantum dots fluorescence and further expand their applications in research and medicine.

Read More »

Maleimide Crosslinker Selection Guide

This guide explains how to select maleimide crosslinkers on linear and multi-arm dPEG® linkers, with pH best practices, thiol/amine selectivity, solubility notes, and examples for ADCs, lipids, and proteins.

Read More »

It Takes Two to Tango, Part 2: Applications of Bioconjugation

In the previous section, we discussed the methods of bioconjugation. And the marriage of a biomolecule and a small molecule has given rise to various modalities commonly used in biomedical research. Here, we focus on the applications in the fields of therapeutics, diagnostics, protein-protein interactions, and nanotechnology.

Read More »
Envisioning the Future of Glycoinformatics

SugarGPT: Envisioning the Future of Glycoinformatics

The body’s autoimmune response has been leveraged by cancer researchers to propel immunotherapy tools into clinical use. Although the main focus has been on the ability of T-cells to fight cancer cells, the involvement of tumor-infiltrating B-cells is also becoming evident. Tumor-infiltrating B lymphocytes (TIL-Bs) are produced in much higher amounts in various cancers than in healthy tissues, which highlights their positive prognostic value (1). However, their exact role in cancer remains controversial, with the demonstration of both positive and negative impacts.

Read More »
08 03 23 banner 1

Adding efficiency and convenience to multiplexing workflows​

Multiplexing has revolutionized immunostaining workflows. It allows the simultaneous detection of multiple targets in the same tissue section and empowers scientists to gather more data while sparing precious samples. But issues with cross-reactivity between reagents can hinder the ability to perform simultaneous double or triple staining. When these issues arise, scientists can use the VectaPlexÔ Antibody Removal Kit to do multiple rounds of labeling and perform multiplexing experiments.

Read More »
08 23 23 banner jpg

Glycans and B-cells: How glycans influence adaptive immunity

The body’s autoimmune response has been leveraged by cancer researchers to propel immunotherapy tools into clinical use. Although the main focus has been on the ability of T-cells to fight cancer cells, the involvement of tumor-infiltrating B-cells is also becoming evident. Tumor-infiltrating B lymphocytes (TIL-Bs) are produced in much higher amounts in various cancers than in healthy tissues, which highlights their positive prognostic value (1). However, their exact role in cancer remains controversial, with the demonstration of both positive and negative impacts.

Read More »